Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Stroke Prevention With Abciximab in Carotid Endarterectomy

Trial Profile

Stroke Prevention With Abciximab in Carotid Endarterectomy

Withdrawn prior to enrolment
Phase of Trial: Phase I/II

Latest Information Update: 23 Dec 2015

At a glance

  • Drugs Abciximab (Primary)
  • Indications Embolism and thrombosis; Stroke
  • Focus Adverse reactions
  • Most Recent Events

    • 17 Dec 2015 Status changed from discontinued to withdrawn prior to enrolment, as reported by ClinicalTrials.gov.
    • 27 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top